SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Gilead Science (GILD) Followers
GILD 118.33-2.7%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jay silberman who wrote (306)7/24/1997 8:48:00 PM
From: Skywatcher   of 961
 
Whoa, long time no post on this puppy. Well I think today is a good day to post what is a whopper of the quarter for this stock.
biz.yahoo.com
Now that's what I call a good earnings report. even with the big hunk payments, the product revenues are going very well. Don't know what their predictions are for the product sales, but this is very promising. Can't believe how much cash these guys have on hand.
375 million
This compares to revenues from product sales of $1,403,000, and other revenues of $803,000, for total revenues of $2,206,000 and net interest income of $3,740,000 for the same quarter in 1996.
The net income for the three months ended June 30, 1997, was $2,711,000 or $0.09 per share,compared to a net loss of $12,158,000 or $0.43 per share for the same quarter in 1996.
The net loss for the six months ended June 30, 1997 was $5,237,000 or $0.18 per share, compared to a net loss of $22,960,000 or $0.85 per share for the six months ended June 30, 1996.
As of June 30, 1997, Gilead had cash, cash equivalents and short-term investments of $337,354,000, compared to $295,963,000 as of December 31, 1996.
This information should shake a few trees in the analyst jungle.
Let's get back to the high 30's
chris
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext